Rosa, Carla Patricia da Costa Pereira,Gusmao de Noronha, Rita,Kiss, Laszlo Erno,Soares da Silva, Patricio Manuel Vieira Araujo,Russo, Domenico,Wahnon, Jorge Bruno Reis,Maton, William
申请号：
UA20150000932
公开号：
UA116542(C2)
申请日:
2013.07.24
申请国别(地区):
乌克兰
年份:
2018
代理人:
摘要：
A compound having the following structure: or a pharmaceutically acceptable salt or derivative thereof. The compound may be used in the treatment or prevention of a disorder selected from appetite regulation, obesity, metabolic disorders, cachexia, anorexia, pain, inflammation, neurotoxicity, neurotrauma, stroke, multiple sclerosis, spinal cord injury, Parkinson's disease, le-vodopa-induced dyskinesia, Huntington's disease, Gilles de la Tourette's syndrome, tardive dyskinesia, dystonia, amyotrophic lateral sclerosis, Alzheimer's disease, epilepsy, schizophrenia, anxiety, depression, insomnia, nausea, emesis, alcohol disorders, drug addictions such as opiates, nicotine, cocaine, alcohol and psychostimulants, hypertension, circulatory shock, myocardial reperlusion injury, atherosclerosis, asthma, glaucoma, retinopathy, cancer, inflammatory bowel disease, acute and chronic liver disease such as hepatitis and liver cirrhosis, arthritis and osteoporosis.
